This is an outdated version published on 2025-12-10. Read the most recent version.

Russia’s Pharmaceutical Imports under Sanctions Period

Authors

DOI:

https://doi.org/10.64545/2072-8042-2025-9-42-59

Keywords:

import substitution, Russian imports, imports, sanctions, imports of pharmaceuticals

Abstract

The article analyzes the changes in pharmaceutical imports to Russia during 2018-2024, which account for about half of the country’s pharmaceutical consumption. Based on data from UN Comtrade, Eurostat, and GACC, a panel of 83 exporting countries was compiled, covering 96% of Russia’s pre-sanction imports. In 2022–2024, the share of imports in pharmaceutical consumption remained largely unchanged, with supplies from “unfriendly” countries continued to dominate. An empirical analysis using a gravity model estimated with PPML method confirms the resilience of imports from the “unfriendly” countries and indicates a decline in medicines alongside an increase in substances supplied from neutral countries.

Author Biography

Alexander Segreevich Firanchuk, The Russian Presidential Academy of National Economy and Public Administration, RANEPA

Candidate of Sciences in Economics, 
Leading Research Fellow at the Laboratory for International Trade Research
of the Institute of Applied Economic Research

Downloads

Published

2025-12-10

Versions

How to Cite

Firanchuk, A. S. (2025). Russia’s Pharmaceutical Imports under Sanctions Period. Russian Foreign Economic Journal, (9), 42–59. https://doi.org/10.64545/2072-8042-2025-9-42-59

Issue

No. 9 (2025)

Section

Foreign trade activity

License

Copyright (c) 2025 Russian Foreign Economic Journal

Creative Commons License

This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.

This work is licensed under CC BY-NC 4.0